휴대형 의료기기 시장 : 제품 유형, 휴대성, 접속성, 용도, 최종 사용자, 유통 채널별 - 세계 시장 예측(2026-2032년)

The Portable Medical Devices Market is projected to grow by USD 139.27 billion at a CAGR of 7.94% by 2032.

Portable medical devices are moving from episodic care tools to connected, patient-centered healthcare infrastructure. Demand is supported by measurable health-system pressures: the World Health Organization links noncommunicable diseases to approximately 74% of global deaths, while cardiovascular disease remains the leading cause of mortality worldwide. These conditions require frequent monitoring, earlier intervention, and care models that extend beyond hospitals.

Adoption is strongest where compact diagnostics, wearable health monitors, portable imaging systems, insulin delivery devices, respiratory support equipment, and remote patient monitoring platforms reduce avoidable clinical visits and improve continuity of care. For manufacturers, providers, and investors, the portable medical devices landscape is increasingly defined by clinical accuracy, cybersecurity, interoperability, reimbursement readiness, usability, and evidence that portable technologies improve outcomes at lower total cost.

Transformative Shifts in the Landscape

The portable medical devices landscape is shifting from standalone hardware toward integrated digital health ecosystems. Bluetooth-enabled monitoring, cloud analytics, smartphone integration, and clinician dashboards now influence purchasing decisions alongside device ergonomics, battery life, and durability. Regulatory expectations are also rising, with the U.S. FDA, EU MDR, and other authorities emphasizing software validation, post-market surveillance, quality management systems, cybersecurity, and human factors engineering.

Care delivery is changing in parallel. Hospitals are using portable medical devices to support step-down care, hospital-at-home programs, and home-based recovery, while payers increasingly evaluate remote patient monitoring through evidence of reduced admissions, improved medication adherence, and stronger chronic disease management. Supply chains are also being redesigned for semiconductor resilience, regional manufacturing, component traceability, and continuity of access to critical sensors and connectivity modules.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the value of portable medical devices by turning continuous data streams into actionable clinical signals. AI-enabled algorithms support arrhythmia detection, glucose trend prediction, respiratory deterioration alerts, image enhancement, fall detection, triage prioritization, and patient risk stratification. The FDA's public list of AI/ML-enabled medical devices has expanded rapidly in recent years, showing accelerating regulatory acceptance when performance, bias controls, cybersecurity safeguards, and clinical validation are documented.

The cumulative impact is strategic rather than incremental. AI increases device differentiation, enables adaptive software functionality, and supports preventive care workflows across remote patient monitoring, chronic disease management, and home healthcare. However, adoption depends on transparent model governance, privacy protection, representative training datasets, human oversight, and integration with electronic health records to avoid alert fatigue, fragmented workflows, and inequitable performance across patient groups.

Key Regional Insights

North America leads adoption through advanced reimbursement pathways, strong medtech innovation, established telehealth infrastructure, and high use of remote patient monitoring in chronic disease care, with the United States anchoring demand for connected ambulatory and home healthcare devices. Canada reinforces regional quality standards through safety-focused procurement and public health access priorities. Europe is shaped by aging populations, stringent EU MDR compliance, data protection requirements, and strong public health procurement, while Germany, France, Italy, Spain, and the United Kingdom prioritize clinically validated portable medical devices that integrate with national digital health programs and interoperable care records.

Asia-Pacific is the fastest-scaling opportunity as China, India, Japan, South Korea, Australia, and ASEAN markets expand access to chronic disease monitoring, portable diagnostics, wearable medical devices, and home healthcare. Latin America is gaining momentum through private hospital networks, expanding digital health adoption, and diabetes and cardiovascular care needs, led by Brazil and Mexico. The Middle East is investing in smart hospitals, connected care, and national health transformation programs, especially across GCC economies, while Africa shows long-term demand for rugged, affordable, battery-efficient portable medical devices suited to decentralized care, mobile clinics, and areas with constrained specialist access.

Key Group Insights

ASEAN demand is supported by expanding private healthcare, medical tourism, urban hospital investment, and government digital health initiatives, with portable diagnostics and maternal, cardiac, respiratory, and diabetes monitoring gaining relevance in both urban and remote settings. The GCC is advancing connected healthcare through hospital modernization, national health data strategies, and high demand for chronic disease management devices, particularly where diabetes, obesity, and cardiovascular risk remain major public health priorities.

The European Union remains a compliance-driven market where EU MDR certification, GDPR-aligned data protection, cybersecurity, and interoperability are central to commercialization. BRICS countries represent scale opportunities due to large patient populations, expanding domestic manufacturing, and policy support for local medtech capacity, though pricing, localization, and regulatory navigation remain critical. G7 markets set global benchmarks for reimbursement, safety, clinical evidence, AI governance, and cybersecurity expectations, while NATO countries increasingly view secure medical technology supply chains, trusted connectivity, and continuity of healthcare operations as part of broader health system resilience.

Key Country Insights

The United States remains the most commercially influential portable medical devices market due to FDA pathways, CMS reimbursement codes for remote physiologic monitoring, and strong provider adoption of ambulatory and home-based care. Canada emphasizes safety, procurement quality, equitable access, and telehealth-enabled care across dispersed populations, while Mexico and Brazil are expanding portable monitoring through private health systems, cardiometabolic disease programs, and growing demand for point-of-care diagnostics. The United Kingdom is advancing NHS digital pathways and virtual ward models, while Germany, France, Italy, and Spain are prioritizing regulated, interoperable portable medical devices for aging populations, chronic disease management, and hospital efficiency. Russia continues to emphasize domestic healthcare capacity and localization where access to imported medical technology may face constraints.

China is scaling domestic medtech production, connected hospital infrastructure, and digital health adoption, while India offers high-volume need for affordable portable diagnostics, connected monitoring, and devices suited to diverse care environments. Japan's aging population drives demand for home healthcare, fall-risk technologies, portable monitoring, and caregiver-support solutions, and South Korea combines strong electronics capabilities with digital hospital adoption and connected care readiness. Australia supports portable medical devices through telehealth use across geographically dispersed care settings, with demand linked to remote care delivery, chronic disease monitoring, and access improvement for rural and underserved communities.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated portable medical devices that demonstrate measurable reductions in hospital utilization, faster diagnosis, better chronic disease control, or improved patient adherence. Product roadmaps should combine miniaturization, battery efficiency, durable design, intuitive interfaces, secure connectivity, and evidence generation across diverse patient populations and real-world care settings.

Commercial teams should align early with reimbursement requirements, procurement criteria, cybersecurity standards, and local regulatory pathways. Strategic partnerships with health systems, digital infrastructure providers, AI developers, clinical research organizations, and contract manufacturers can accelerate market entry, while cybersecurity-by-design, post-market monitoring, transparent AI governance, and interoperability with electronic health records should be treated as core competitive advantages in the portable medical devices industry.

Research Methodology

This executive summary is based on secondary research from recognized public health, regulatory, and industry sources, including WHO disease burden data, FDA digital health and AI/ML-enabled medical device resources, EU MDR guidance, national telehealth policies, public reimbursement documentation, and published healthcare infrastructure indicators. Insights were triangulated across regulatory developments, reimbursement trends, clinical adoption patterns, digital health policies, and regional healthcare investment activity.

The analysis applies a structured market interpretation framework, assessing demand drivers, technology shifts, competitive positioning, regional readiness, and commercialization risks without relying on market sizing, market share, or forecasting claims. Emphasis was placed on verifiable indicators such as chronic disease prevalence, aging demographics, device regulation, remote patient monitoring adoption, cybersecurity expectations, digital health infrastructure, and payer movement toward preventive and home-based care.

Conclusion

Portable medical devices are becoming essential to modern healthcare because they support earlier diagnosis, continuous monitoring, home-based recovery, remote patient management, and more efficient use of clinical resources. The strongest opportunities will favor organizations that combine reliable hardware with validated software, secure data exchange, AI-enabled decision support, and clear clinical evidence.

As healthcare systems confront aging populations, workforce shortages, chronic disease burdens, and rising demand for decentralized care, portable medical devices will remain central to care transformation. Leadership will depend on trust, regulatory discipline, interoperability, cybersecurity, and the ability to prove value across patients, providers, payers, and public health systems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Portable Medical Devices Market, by Product Type

• 7.1. Assisted Devices
  • 7.1.1. Portable Oxygen Concentrators
  • 7.1.2. Portable Ventilators
• 7.2. Diagnostic Imaging Devices
  • 7.2.1. Portable Ultrasound
  • 7.2.2. Portable X Ray
• 7.3. Drug Delivery Devices
  • 7.3.1. Infusion Pumps
  • 7.3.2. Insulin Pumps
• 7.4. Monitoring Devices
  • 7.4.1. Ecg Monitors
  • 7.4.2. Glucose Monitors
  • 7.4.3. Respiratory Monitors
  • 7.4.4. Vital Sign Monitors
• 7.5. Therapeutic Devices
  • 7.5.1. Nebulizers
  • 7.5.2. Suction Pumps

8. Portable Medical Devices Market, by Portability

• 8.1. Handheld
• 8.2. Transportable
• 8.3. Wearable

9. Portable Medical Devices Market, by Connectivity

• 9.1. Wired
• 9.2. Wireless
  • 9.2.1. Bluetooth
  • 9.2.2. Cellular
  • 9.2.3. Wi Fi

10. Portable Medical Devices Market, by Application

• 10.1. Cardiovascular
  • 10.1.1. Blood Pressure Monitoring
  • 10.1.2. Ecg Monitoring
• 10.2. Diabetes Management
  • 10.2.1. Continuous Glucose Monitoring
  • 10.2.2. Insulin Delivery
• 10.3. Neurology
• 10.4. Respiratory
  • 10.4.1. Sleep Apnea Devices
  • 10.4.2. Spirometry

11. Portable Medical Devices Market, by End User

• 11.1. Ambulatory Surgical Centers
• 11.2. Clinics
• 11.3. Diagnostic Laboratories
• 11.4. Homecare Settings
• 11.5. Hospitals

12. Portable Medical Devices Market, by Distribution Channel

• 12.1. Online
• 12.2. Offline

13. Portable Medical Devices Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Portable Medical Devices Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Portable Medical Devices Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Abbott Laboratories
• 17.2. Align Technology, Inc.
• 17.3. AliveCor, Inc.
• 17.4. Baxter International Inc.
• 17.5. Becton, Dickinson and Company
• 17.6. Boston Scientific Corporation
• 17.7. Butterfly Network, Inc.
• 17.8. Dexcom, Inc.
• 17.9. Dragerwerk AG & Co. KGaA
• 17.10. Fresenius Medical Care AG & Co. KGaA
• 17.11. General Electric Company
• 17.12. Hologic, Inc.
• 17.13. ICU Medical, Inc.
• 17.14. Inogen, Inc.
• 17.15. Insulet Corporation
• 17.16. Johnson & Johnson
• 17.17. Koninklijke Philips N.V.
• 17.18. Masimo Corporation
• 17.19. Medtronic plc
• 17.20. Nihon Kohden Corporation
• 17.21. OMRON Corporation
• 17.22. Owlet, Inc.
• 17.23. ResMed Inc.
• 17.24. Siemens Healthineers AG
• 17.25. Smith & Nephew PLC
• 17.26. Stryker Corporation
• 17.27. Tandem Diabetes Care, Inc.
• 17.28. Withings
• 17.29. Zoll Medical Corporation